Statins were found to lower the chances of dying from any cause and reduced the risk of major cardiac events for all patients ...
A large cohort study found that statins significantly reduce the risk of death and major cardiovascular events in adults with ...
Health care professionals caution on the persistent/residual cardiovascular risk that remains in patients who have their LDL well controlled on statin therapy. Deepak L. Bhatt, MD, MPH: One thing that ...
SaveHealth reports on popular statin medications that lower cholesterol and cardiovascular risks, highlighting their benefits ...
Matthew J. Budoff, MD, comments on the role of statin therapy for dyslipidemia and shares considerations for appropriate selection and use. Transcript Deepak L. Bhatt, MD, MPH: I’m glad you brought in ...
Lifetime use of standard statin increased QALYs by 0.24 to 0.70, with further increase seen for higher-intensity statins. HealthDay News — Statin therapy improves health outcomes and is cost-effective ...
When I tried statin therapy as part of an experiment, I quickly developed a common side effect. But what concerned me wasn’t ...
There is decreased risk for venous thromboembolism in women aged 50 to 64 years receiving hormone therapy and statin therapy. Statin therapy is associated with a decreased risk for venous ...
More than one in four patients in the United States with atherosclerotic cardiovascular disease (ASCVD) are not on a guideline-recommended statin or other lipid-lowering therapy, with suboptimal ...
Taking a statin medication is an effective, safe, and low-cost way to lower cholesterol and reduce risk of cardiovascular events. Despite clinicians recommending that many patients with diabetes take ...
Please provide your email address to receive an email when new articles are posted on . Statin therapy may have a significant benefit on progression of idiopathic pulmonary fibrosis, according to ...
Please provide your email address to receive an email when new articles are posted on . In a cross-sectional, retrospective study, Kautzky-Willer and colleagues analyzed data from all Austrians with ...